How do people afford BENLYSTA?
The BENLYSTA Co-pay Program helps eligible commercially insured patients with their out-of-pocket costs for BENLYSTA up to $15,000 for 12 months. Work with your doctor to apply for the program through BENLYSTA Gateway or visit BENLYSTACopayProgram.com to apply. *Eligibility restrictions and program maximums apply.
What is the cost of BENLYSTA infusion?
There are two ways to take BENLYSTA: Self-injection at home: The list price for a single dose of BENLYSTA Injection for Subcutaneous Use for self-injection is $1,070.54. (BENLYSTA Injection for Subcutaneous Use is sold in a 4 pack at the price of $4,282.17).
How much does belimumab cost?
Table 5CDR Cost Comparison Table of Treatments for Adults With SLEDrug/ comparatorStrengthPrice ($)Belimumab (Benlysta)200 mg/mL421.7900a120 mg/5 mL 400 mg/20 mL Single-use vials293.5700b 978.5600bAntimalarial drugsHydroxychloroquine (Plaquenil, generic)200 mg0.15768 more rows
Do BENLYSTA injections hurt?
If you are injecting in yourself do it very slowly with the prefill one but not the auto inject. The auto inject will release the med very fast and it's very painful. I been using it for 5 years now. Still have a lot of joint pain but the fatigue, the brain fog and the other symptoms are much better.
How much does BENLYSTA cost per month?
Benlysta prices without insurance will vary depending on where you buy it and the amount you buy. As a guide, Benlysta intravenous powder for injection 120 mg usually costs $580 for 1 powder for injection. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.
Does BENLYSTA cause weight gain?
Changes in weight, such as weight gain or weight loss, weren't reported in people taking Benlysta during clinical trials. If you experience changes in your weight, talk with your doctor. In some cases, changes in weight may be related to side effects from taking Benlysta.
How often do you get BENLYSTA infusions?
FDA-Approved Indications and Dosing Benlysta is administered as a 1-hour IV infusion only and given every 4 weeks after the loading phase.
Does hydroxychloroquine help lupus?
Most people with lupus take hydroxychloroquine throughout their lives. It helps control lupus symptoms with very few side effects. Hydroxychloroquine may also help prevent blood clots and organ damage from lupus.
How long does BENLYSTA take to work?
Benlysta starts working from your very first injection/infusion, but it may take up to 8 weeks before you notice an improvement in some symptoms, and from 4 to 8 months before the full effects at resolving fatigue, joint, and muscle pain are seen. Once an improvement is seen these effects usually persist long term.
Is BENLYSTA a form of chemo?
Is BENLYSTA a chemotherapy? No, BENLYSTA is not chemotherapy – it's a biologic therapy, delivered either through an IV infusion or as a self-injection. It works by reducing certain cells in your immune system that can make lupus active.
What are the long term effects of BENLYSTA?
In controlled clinical trials of BENLYSTA administered intravenously, serious infections occurred in 6.0% and 5.2% of patients receiving BENLYSTA and placebo, respectively. The most frequent serious infections included pneumonia, urinary tract infection, cellulitis, and bronchitis.
How will I feel after BENLYSTA infusion?
The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously).
How long does it take for BENLYSTA infusion to work?
Benlysta starts working from your very first injection/infusion, but it may take up to 8 weeks before you notice an improvement in some symptoms, and from 4 to 8 months before the full effects at resolving fatigue, joint, and muscle pain are seen. Once an improvement is seen these effects usually persist long term.
How much is lupus treatment?
A new treatment for lupus, given through IV infusion, Benlysta[1] costs about $35,000 per year, according to the National Institutes of Health. According to a fact sheet[2] from the Lupus Foundation of America, the yearly cost of treatment for lupus averages more than $12,600 per patient.
How much does BENLYSTA cost in Canada?
Benlysta® is priced at $277.20 for 120mg (5ml vial) and $924.00 for 400mg (20ml vial). The annual cost for an average 75kg patient is $26,334 for the first year, followed by $22,822 for each subsequent year.
How often do you take BENLYSTA?
For the first 3 infusions, BENLYSTA is given once every 2 weeks. After that, BENLYSTA is given once every 4 weeks.
What is Benlysta?
Benlysta is a human monoclonal antibody that was approved for the treatment of lupus in adults by the U.S. Food and Drug Administration (FDA) in 20...
How does Benlysta work?
Benlysta is a human monoclonal antibody that specifically recognizes and blocks the biological activity of B-lymphocyte stimulator, or BLyS® (prono...
Who developed Benlysta?
Benlysta was co-developed by Human Genome Sciences (HGS) and GlaxoSmithKline (GSK). HGS has since been purchased by GSK. See our Benlysta® Develop...
What does an FDA approval of Benlysta mean for people with lupus?
Benlysta represents a breakthrough in the treatment of lupus. Benlysta is the first drug approved to treat lupus in more than 50 years AND is the f...
What makes Benlysta different from other lupus treatments?
Benlysta is the FIRST FDA-approved medication specifically designed for the treatment of lupus. Benlysta targets specific immune cells, rather than...
Where can I find out more information about Benlysta?
Benlysta Gateway is a centralized resource for patients and health care providers for one-on-one services and support. For more information call 1-...
Who should take Benlysta? Will it work for everyone?
Each person with lupus is unique, and Benlysta may not be an option for everyone. You will need to discuss with your doctor whether Benlysta may be...
Is Benlysta approved for use in children with lupus?
Yes. On April 26, 2019 the U.S. Food and Drug Administration approved the use of Benlysta in children as young as five years of age. Benlysta was...
Will there be any further clinical trials on Benlysta?
Yes, there are ongoing trials studying the outcomes and safety of Benlysta in many different people. Learn more about engaging in lupus research .
What is Benlysta?
Benlysta is a human monoclonal antibody that was approved for the treatment of lupus by the U.S. Food and Drug Administration (FDA) on March 9, 2011 and for lupus nephritis on December 17, 2020. A monoclonal antibody is a type of protein made in the laboratory that is developed to find and attach to only one type of substance in the body.
How is Benlysta administered?
In adults and children five years and up with SLE, Benlysta can be administered by a medical professional through an IV (intravenous) infusion directly into the vein; adults can self-administer an injection under the skin as well. Benlysta now can be administered by IV infusion or as an under-the-skin injection for adults who have active lupus nephritis.
What does an FDA approval of Benlysta mean for people with lupus?
Benlysta represents a breakthrough in the treatment of lupus. Benlysta is the first drug approved to treat lupus in more than 50 years AND is the first drug developed specifically for lupus since the disease was discovered more than a century ago! Successful treatment of lupus will require an arsenal of safe, effective, and tolerable treatments. The approval of Benlysta (approved March 2011) is a significant first step toward reaching that goal.
How does Benlysta work?
Benlysta is a human monoclonal antibody that specifically recognizes and blocks the biological activity of B-lymphocyte stimulator, or BLyS® (pronounced bliss), a naturally occurring protein which was discovered by scientists at Human Genome Sciences (HGS). Elevated levels of BLyS prolong the survival of B cells which can contribute to the production of autoantibodies – antibodies that target the body’s own tissues. Studies have shown that Benlysta can reduce autoantibody levels and help control autoimmune disease activity.
Who developed Benlysta?
Benlysta was co-developed by Human Genome Sciences (HGS) and GlaxoSmithKline (GSK). HGS has since been purchased by GSK. See our Benlysta® Development Fact Sheet for more information.
Where can I find out more information about Benlysta?
Benlysta Gateway is a centralized resource for patients and health care providers for one-on-one services and support. For more information call 1-877-4-Benlysta, Monday through Friday, 8AM to 8PM (EST). You can also visit www.benlysta.com for more information.
Will there be any further clinical trials on Benlysta?
Yes, there are ongoing trials studying the outcomes and safety of Benlysta in many different people. Learn more about engaging in lupus research .
